Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24


An erythroid-specific ATP2B4 enhancer mediates red blood cell hydration and malaria susceptibility.

Lessard S, Gatof ES, Beaudoin M, Schupp PG, Sher F, Ali A, Prehar S, Kurita R, Nakamura Y, Baena E, Ledoux J, Oceandy D, Bauer DE, Lettre G.

J Clin Invest. 2017 Aug 1;127(8):3065-3074. doi: 10.1172/JCI94378. Epub 2017 Jul 17.


Strict in vivo specificity of the Bcl11a erythroid enhancer.

Smith EC, Luc S, Croney DM, Woodworth MB, Greig LC, Fujiwara Y, Nguyen M, Sher F, Macklis JD, Bauer DE, Orkin SH.

Blood. 2016 Nov 10;128(19):2338-2342. doi: 10.1182/blood-2016-08-736249. Epub 2016 Oct 5.


Surgical Site Infection in Diabetic and Non-Diabetic Patients Undergoing Laparoscopic Cholecystectomy.

Ismat U, Khan A, Nawaz A, Mansoor R, Malik AA, Sher F, Ayyaz M.

J Coll Physicians Surg Pak. 2016 Feb;26(2):100-2. doi: 02.2016/JCPSP.100102.


Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin.

Masuda T, Wang X, Maeda M, Canver MC, Sher F, Funnell AP, Fisher C, Suciu M, Martyn GE, Norton LJ, Zhu C, Kurita R, Nakamura Y, Xu J, Higgs DR, Crossley M, Bauer DE, Orkin SH, Kharchenko PV, Maeda T.

Science. 2016 Jan 15;351(6270):285-9. doi: 10.1126/science.aad3312.


BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis.

Canver MC, Smith EC, Sher F, Pinello L, Sanjana NE, Shalem O, Chen DD, Schupp PG, Vinjamur DS, Garcia SP, Luc S, Kurita R, Nakamura Y, Fujiwara Y, Maeda T, Yuan GC, Zhang F, Orkin SH, Bauer DE.

Nature. 2015 Nov 12;527(7577):192-7. doi: 10.1038/nature15521. Epub 2015 Sep 16.


Absence of colossal magnetoresistance in the oxypnictide PrMnAsO0.95F0.05.

Wildman EJ, Sher F, Mclaughlin AC.

Inorg Chem. 2015 Mar 16;54(6):2536-42. doi: 10.1021/ic502445t. Epub 2015 Feb 25.


Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial.

Gladstone DJ, Dorian P, Spring M, Panzov V, Mamdani M, Healey JS, Thorpe KE; EMBRACE Steering Committee and Investigators.

Stroke. 2015 Apr;46(4):936-41. doi: 10.1161/STROKEAHA.115.008714. Epub 2015 Feb 19.


Atrial fibrillation in patients with cryptogenic stroke.

Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O'Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M; EMBRACE Investigators and Coordinators.

N Engl J Med. 2014 Jun 26;370(26):2467-77. doi: 10.1056/NEJMoa1311376.


"Hard-soft" synthesis of SrCrO3-δ superstructure phases.

Arévalo-López AM, Rodgers JA, Senn MS, Sher F, Farnham J, Gibbs W, Attfield JP.

Angew Chem Int Ed Engl. 2012 Oct 22;51(43):10791-4. doi: 10.1002/anie.201206203. Epub 2012 Sep 26. No abstract available.


Dynamic changes in Ezh2 gene occupancy underlie its involvement in neural stem cell self-renewal and differentiation towards oligodendrocytes.

Sher F, Boddeke E, Olah M, Copray S.

PLoS One. 2012;7(7):e40399. doi: 10.1371/journal.pone.0040399. Epub 2012 Jul 12.


Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice.

Sher F, Amor S, Gerritsen W, Baker D, Jackson SL, Boddeke E, Copray S.

Cell Transplant. 2012;21(9):1883-97. doi: 10.3727/096368911X637443. Epub 2012 Mar 28.


Ezh2 expression in astrocytes induces their dedifferentiation toward neural stem cells.

Sher F, Boddeke E, Copray S.

Cell Reprogram. 2011 Feb;13(1):1-6. doi: 10.1089/cell.2010.0052. Epub 2010 Oct 27.


Bioluminescence imaging of Olig2-neural stem cells reveals improved engraftment in a demyelination mouse model.

Sher F, van Dam G, Boddeke E, Copray S.

Stem Cells. 2009 Jul;27(7):1582-91. doi: 10.1002/stem.76.


Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging.

Copray S, Huynh JL, Sher F, Casaccia-Bonnefil P, Boddeke E.

Glia. 2009 Nov 15;57(15):1579-87. doi: 10.1002/glia.20881. Review.


Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs).

Kernan WN, Viscoli CM, Demarco D, Mendes B, Shrauger K, Schindler JL, McVeety JC, Sicklick A, Moalli D, Greco P, Bravata DM, Eisen S, Resor L, Sena K, Story D, Brass LM, Furie KL, Gutmann L, Hinnau E, Gorman M, Lovejoy AM, Inzucchi SE, Young LH, Horwitz RI; IRIS Trial Investigators.

Neurology. 2009 Apr 14;72(15):1345-51. doi: 10.1212/WNL.0b013e3181a0fda3.


Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapy.

Sher F, Balasubramaniyan V, Boddeke E, Copray S.

Curr Opin Neurol. 2008 Oct;21(5):607-14. doi: 10.1097/WCO.0b013e32830f1e50. Review.


Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2.

Sher F, Rössler R, Brouwer N, Balasubramaniyan V, Boddeke E, Copray S.

Stem Cells. 2008 Nov;26(11):2875-83. doi: 10.1634/stemcells.2008-0121. Epub 2008 Aug 7.


Chemical tuning of positive and negative magnetoresistances, and superconductivity in 1222-type ruthenocuprates.

McLaughlin AC, Begg L, Harrow C, Kimber SA, Sher F, Attfield JP.

J Am Chem Soc. 2006 Sep 27;128(38):12364-5.


The relationship between diffusion anisotropy and time of onset after stroke.

Bhagat YA, Emery DJ, Shuaib A, Sher F, Rizvi NH, Akhtar N, Clare TL, Leatherdale T, Beaulieu C.

J Cereb Blood Flow Metab. 2006 Nov;26(11):1442-50. Epub 2006 Mar 22.


Retraction: Negative lattice expansion from the superconductivity-antiferromagnetism crossover in ruthenium copper oxides.

Mclaughlin AC, Sher F, Attfield JP.

Nature. 2005 Oct 13;437(7061):1057. No abstract available.


Supplemental Content

Loading ...
Support Center